fda warns hims & hers for selling unapproved compounded semaglutide Novo Nordisk calls out dangers of GLP-1s in new ad FDA issued 25 warning letters
Description
The FDA and DEA have issued guidance clarifying that licensed 503A compounding pharmacies may legally compound semaglutide for individual patients when a licensed prescriber provides a valid prescription
(Great for battling addiction, terrible for taking last-minute vacations.) One of her clients, she says, had been looking forward to leaving her job
Protein intake is very important as these people can lose a significant amount of weight on the medications, she said
Book Your Weight Loss Consult Today
